Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ziyin Ningshen is a traditional Chinese medicine (TCM) formula used as an adjunctive therapy for neuropsychiatric conditions, particularly in patients with schizophrenia and sleep disorders. It is typically administered in combination with Western pharmaceuticals to improve clinical symptoms such as sleep quality and cognitive function. The formulation is based on TCM principles of nourishing yin ("ziyin") and calming the spirit ("ningshen"), aiming to restore balance in patients exhibiting yin deficiency syndromes. While the precise herbal composition may vary by manufacturer or study, it generally includes herbs known for their sedative, anxiolytic, and neuroprotective properties according to TCM theory. Mechanistic studies are limited; however, its effects are believed to involve modulation of neurotransmitter systems and improvement of sleep architecture[6][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ziyin Ningshen.